Prime Medicine (PRME) Other Working Capital Changes (2021 - 2026)

Prime Medicine (PRME) has 6 years of Other Working Capital Changes data on file, last reported at -$856000.0 in Q1 2026.

• Quarterly Other Working Capital Changes rose 72.39% year-over-year to -$856000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.6 million (up 8.51% YoY) and the FY2025 annual result came in at -$5.4 million, up 17.01% from the prior year.
• Other Working Capital Changes rose to -$856000.0 in Q1 2026, from -$1.7 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $6.9 million in Q3 2024 to a low of -$2.6 million in Q4 2025.
• A 5-year average of $1.3 million and a median of $658000.0 in 2022 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2023 — Other Working Capital Changes surged 299.06% — and 2025, when it plunged 276.21%.
• Tracing PRME's Other Working Capital Changes over 5 years: stood at -$2.7 million in 2022, then surged by 344.2% to $6.6 million in 2023, then plunged by 106.91% to -$454000.0 in 2024, then sank by 276.21% to -$1.7 million in 2025, then jumped by 49.88% to -$856000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$856000.0 (Q1 2026), -$1.7 million (Q4 2025), and -$1.6 million (Q3 2025), per Business Quant data.